Amelie Harle on Aprepitant's Effectiveness in Treating Cough in Lung Cancer

Article

Amelie Harle, an oncologist at Christie Hospital in Manchester, United Kingdom, discusses the possibility of using aprepitant (Emend) to treat cough in patients with lung cancer.

Amelie Harle, an oncologist at Christie Hospital in Manchester, United Kingdom, discusses the possibility of using aprepitant (Emend) to treat cough in patients with lung cancer.

Harle said that there are few, if any, evidence-based treatments to treat cough for these patients, so she did a study involving 20 people with lung cancer. She noticed that aprepitant did, in fact, reduce cough frequency because it targets the NK-1 pathway, which, in animal studies, was proven to effect cough.

Since her study was small, Harle said that the next step would be a larger and longer study, with two groups of patients: one receiving aprepitant, and the other receiving a placebo to see the true effectiveness of the drug.

Related Videos
Meaghan Mooney, B.S.N., RN, OCN, during the Extraordinary Healer interview
Colleen O’Leary, DNP, RN, AOCNS, EBP-C, LSSYB, in an interview with Oncology Nursing News.
Michelle H. Johann, DNP, RN, PHN, CPAN, WTA, in an interview with Oncology Nursing News explaining surgical path cards
Alison Tray, of Hartford Healthcare, discusses her team's research on a multidisciplinary team approach to manage the cancer drug shortage
Related Content
© 2024 MJH Life Sciences

All rights reserved.